Seamless Therapeutics

Tessera

The company develops genome engineering platforms to write therapeutic DNA sequences into cells for clinicians and researchers treating genetic diseases.

Scenic Biotech

This company develops disease-modifying small molecule therapeutics for patients with rare genetic and neurodegenerative disorders using its proprietary genetic modifier discovery platform.

Beam Therapeutics

The company develops precision genetic medicines using base editing technology to treat patients with serious genetic diseases such as sickle cell disease.

Alia Therapeutics

The company develops gene editing medicines for patients with genetic diseases.

Stylus Medicine

This biotechnology company develops in vivo genetic medicines using engineered recombinases and lipid nanoparticles for patients with cancer, autoimmune and genetic diseases.

Replace Therapeutics

The company develops genome editing technology to insert and delete small DNA sequences for biotechnology firms and healthcare researchers.

EdiTy Therapeutics

This company develops immune cell delivery platforms to transport therapeutic proteins into diseased cells for patients with cancer and genetic disorders.

Shape Therapeutics

The company develops programmable RNA medicines and delivery systems for patients with genetic disorders and other hard-to-treat diseases.